100,127 Shares in Baxter International Inc. $BAX Acquired by Quantbot Technologies LP

Quantbot Technologies LP bought a new position in Baxter International Inc. (NYSE:BAX) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 100,127 shares of the medical instruments supplier’s stock, valued at approximately $2,135,000.

A number of other institutional investors and hedge funds have also bought and sold shares of BAX. BlackRock Inc. purchased a new position in shares of Baxter International during the second quarter worth approximately $1,744,874,000. Pzena Investment Management LLC purchased a new stake in shares of Baxter International in the 2nd quarter valued at $1,392,098,000. Equity Investment Corp purchased a new stake in shares of Baxter International in the 2nd quarter valued at $146,815,000. Bank of New York Mellon Corp bought a new position in shares of Baxter International during the 2nd quarter valued at $68,036,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new position in Baxter International in the 2nd quarter worth $51,958,000. 90.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

BAX has been the subject of several analyst reports. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Stifel Nicolaus lifted their price objective on Baxter International from $19.00 to $24.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. The Goldman Sachs Group boosted their target price on Baxter International from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, July 15th. Weiss Ratings upgraded Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, July 31st. Finally, Citigroup upgraded Baxter International from a “sell” rating to a “neutral” rating and raised their price target for the stock from $17.00 to $28.00 in a research report on Friday, July 31st. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Baxter International currently has an average rating of “Hold” and an average price target of $22.45.

Baxter International Trading Up 0.6%

Shares of BAX opened at $26.50 on Tuesday. The stock has a market capitalization of $13.70 billion, a P/E ratio of -12.80, a PEG ratio of 3.99 and a beta of 0.60. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 1.39. The firm has a fifty day simple moving average of $23.74 and a two-hundred day simple moving average of $20.41. Baxter International Inc. has a twelve month low of $15.73 and a twelve month high of $30.00.

Baxter International (NYSE:BAX) last announced its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The business had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same quarter last year, the firm earned $0.59 EPS. The company’s revenue was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, research analysts anticipate that Baxter International Inc. will post 2.04 EPS for the current year.

Baxter International Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s dividend payout ratio (DPR) is presently -1.93%.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.